Financials in USD. Standardized financial statements.
A compact view of how Viveve Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $6.43M | $5.48M | $6.57M | $18.52M | $15.29M | $7.14M | $1.45M | $90,000 | $1.27M | $1.08M |
| Revenue Growth? | +17.3% | -16.6% | -64.5% | +21.1% | +114.1% | +393.5% | +1507.8% | -92.9% | +18.0% | 0.0% |
| Cost of Revenue? | $5.81M | $5.18M | $5.55M | $11.20M | $7.84M | $4.61M | $985,000 | $50,000 | $531,000 | $541,000 |
| Gross Profit? | $620,000 | $296,000 | $1.02M | $7.32M | $7.44M | $2.53M | $462,000 | $40,000 | $743,000 | $539,000 |
| Gross Margin? | +9.6% | +5.4% | +15.5% | +39.5% | +48.7% | +35.4% | +31.9% | +44.4% | +58.3% | +49.9% |
| Operating Expenses? | $22.17M | $18.79M | $30.95M | $52.28M | $41.17M | $21.23M | $12.45M | $5.70M | $5.45M | $4.66M |
| Operating Income? | -$21.55M | -$18.50M | -$29.94M | -$44.97M | -$33.73M | -$18.70M | -$11.99M | -$5.66M | -$4.70M | -$4.13M |
| EBITDA? | -$19.63M | -$19.32M | -$30.68M | -$44.17M | -$33.34M | -$18.63M | -$11.93M | -$5.66M | -$4.65M | -$4.08M |
| Income Before Tax | -$21.77M | -$21.53M | -$41.90M | -$49.32M | -$36.96M | -$20.11M | -$12.43M | -$6.18M | $3.50M | -$8.39M |
| Income Tax Expense | $256,000 | $383,000 | $4.82M | -$142,000 | -$329,000 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$22.03M | -$21.91M | -$42.53M | -$49.18M | -$36.63M | -$20.11M | -$12.43M | -$6.18M | $3.50M | -$8.39M |
| EPS? | $-2.65 | $-16.56 | $-121.91 | $-1583.50 | $-2093.62 | $-2180.76 | $-2474.31 | $-2744.23 | $22429.00 | $-209675.00 |
| Diluted EPS? | $-2.65 | $-16.56 | $-121.91 | $-1583.50 | $-2093.62 | $-2180.76 | $-2474.31 | $-2744.23 | $22429.00 | $-209675.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality